Lung cancer is the leading cause of cancer-related deaths worldwide – but it doesn't affect everyone equally.
Data shows wide regional variation of lung cancer diagnoses, as well as huge differentials linked to socio-economic factors and class.
In this episode Becky Slack is joined by a panel including a leading clinical expert, Professor David Baldwin, Lorraine Dallas from the Roy Castle Lung Cancer Foundation, as well as David Long from the leading pharmaceuticals company and our sponsor for this episode, MSD.
They discuss the root of lung cancer inequalities and how they can be mitigated.
This episode has been fully funded by MSD, one of the world's leading pharmaceutical companies active in several key areas of global health, including immunisation and oncology. Learn more about the work they do following the science to tackle some of the world's greatest health threats at www.msd.com
Listen to all our Spotlight on Policy episodes here: https://podfollow.com/spotlight-on-policy-from-the-new-statesman
LISTEN AD-FREE:
📱Download the New Statesman app
MORE FROM THE NEW STATESMAN:
❓ Ask a question – we answer them every Friday
⏰ Get our daily politics newsletter every morning
✍️ Enjoy the best of our writing via email every Saturday
JOIN US:
⭐️ Get full access to all our reporting and analysis with a print + digital subscription
Hosted on Acast. See acast.com/privacy for more information.
